US Stock MarketDetailed Quotes

INVO INVO Bioscience

Watchlist
  • 1.0700
  • -0.0500-4.46%
Close May 15 16:00 ET
  • 1.0704
  • +0.0004+0.04%
Post 19:15 ET
4.06MMarket Cap-208P/E (TTM)

INVO Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
27.99%-4.76M
28.81%-714.88K
24.33%-1.25M
12.20%-1.64M
44.74%-1.15M
-9.51%-6.6M
33.55%-1M
-2.40%-1.65M
-59.56%-1.87M
-19.75%-2.08M
Net income from continuing operations
26.24%-8.03M
27.91%-1.99M
51.03%-1.25M
20.03%-2.24M
8.05%-2.55M
-63.68%-10.89M
-2,952.08%-2.77M
-2.75%-2.55M
-54.17%-2.8M
-13.08%-2.77M
Operating gains losses
11.46%223.55K
2,013.04%191.44K
-61.98%8.16K
-103.21%-3.79K
-61.00%27.74K
19.08%200.56K
-104.68%-10.01K
-80.83%21.47K
--117.98K
--71.12K
Depreciation and amortization
159.89%200.89K
610.12%141.6K
3.91%20.5K
-9.58%-38.15K
6.21%76.95K
-53.46%77.3K
-74.87%19.94K
-57.49%19.73K
-209.99%-34.82K
737.14%72.45K
Other non cash items
421.38%900.13K
56.56%152.87K
691.47%356.16K
--167.72K
--223.38K
-85.47%172.64K
-43.67%97.64K
-42.18%45K
----
----
Change In working capital
-68.17%471.7K
-52.77%524.67K
-309.72%-649.17K
-82.20%44.08K
396.73%552.12K
141.10%1.48M
136.14%1.11M
171.27%309.55K
238.51%247.68K
74.13%-186.07K
-Change in receivables
-137.64%-63.4K
-307.14%-23.77K
-182.43%-41.87K
1,010.16%24.81K
-173.59%-22.57K
7.27%-26.68K
-860.16%-5.84K
-861.48%-14.83K
-99.53%2.24K
98.37%-8.25K
-Change in inventory
-103.74%-905
-162.24%-10.29K
1,283.27%25.8K
-172.01%-9.1K
-6.69%-7.32K
207.90%24.17K
531.60%16.53K
104.71%1.87K
-28.07%12.64K
-130.37%-6.86K
-Change in prepaid assets
-566.88%-432.09K
-323.63%-257.07K
116.51%9.49K
-534.93%-123.84K
-211.19%-60.68K
174.15%92.55K
333.88%114.95K
-483.20%-57.47K
82.16%-19.5K
191.93%54.57K
-Change in payables and accrued expense
15.56%1.05M
-27.43%478.6K
-67.49%72.35K
-154.09%-2.58K
2,551.39%498.17K
570.71%905.62K
872.40%659.48K
-0.46%222.58K
102.18%4.76K
-91.26%18.79K
-Change in other current liabilities
-2,112.20%-141.38K
2,539.82%28.64K
-13,462.99%-171.85K
-0.77%58.6K
-4.35%-56.77K
113.05%7.03K
103.31%1.09K
107.55%1.29K
4,007.09%59.06K
-890.80%-54.41K
-Change in other working capital
-86.87%62.93K
-4.97%308.55K
-447.90%-543.09K
-48.97%96.18K
205.99%201.29K
113.65%479.36K
111.16%324.68K
335.39%156.11K
295.73%188.49K
56.69%-189.92K
Cash from discontinued investing activities
Operating cash flow
27.99%-4.76M
28.81%-714.88K
24.33%-1.25M
12.20%-1.64M
44.74%-1.15M
-9.51%-6.6M
33.55%-1M
-2.40%-1.65M
-59.56%-1.87M
-19.75%-2.08M
Investing cash flow
Cash flow from continuing investing activities
-2,971.87%-2.49M
287.86%33.29K
-74,973.70%-2.26M
-5,234.66%-261.51K
89.68%-8.45K
96.23%-81.22K
100.94%8.58K
99.06%-3.01K
99.19%-4.9K
73.50%-81.89K
Net PPE purchase and sale
-4,023.52%-444.72K
-55,655.56%-75K
-4,091.21%-108.22K
-9,643.11%-261.51K
--0
97.41%-10.79K
-99.96%135
99.65%-2.58K
---2.68K
---5.65K
Net intangibles purchase and sale
--0
--0
--0
--0
--0
95.01%-1.94K
--0
86.51%-426
90.52%-607
96.86%-910
Net business purchase and sale
-2,893.41%-2.05M
1,181.84%108.29K
---2.15M
--0
88.79%-8.45K
95.97%-68.49K
100.58%8.45K
--0
99.82%-1.61K
---75.33K
Cash from discontinued investing activities
Investing cash flow
-2,971.87%-2.49M
287.86%33.29K
-74,973.70%-2.26M
-5,234.66%-261.51K
89.68%-8.45K
96.23%-81.22K
100.94%8.58K
99.06%-3.01K
99.19%-4.9K
73.50%-81.89K
Financing cash flow
Cash flow from continuing financing activities
578.31%7.39M
-117.69%-141.53K
17,753.12%4.45M
-169.86K
933.34%3.26M
-71.10%1.09M
-76.48%800K
-25.2K
0
-14.83%315K
Net issuance payments of debt
108.11%1.66M
-117.69%-141.53K
--1.45M
---190.15K
--544K
420.00%800K
--800K
--0
--0
--0
Net common stock issuance
1,867.55%5.7M
---23.05K
11,989.13%3M
--20.3K
759.89%2.71M
-92.06%289.8K
--0
---25.2K
--0
--315K
Proceeds from stock option exercised by employees
--25.43K
--23.05K
--0
---1
--2.38K
--0
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
578.31%7.39M
-117.69%-141.53K
17,753.12%4.45M
---169.86K
933.34%3.26M
-71.10%1.09M
-76.48%800K
---25.2K
--0
-14.83%315K
Net cash flow
Beginning cash position
-98.41%90.14K
269.46%1.06M
-94.27%112.49K
-43.01%2.19M
-98.41%90.14K
-43.70%5.68M
-93.94%285.7K
-70.46%1.96M
-54.41%3.84M
-43.70%5.68M
Current changes in cash
102.54%142.29K
-320.90%-823.12K
156.25%943.06K
-10.55%-2.08M
213.72%2.1M
-26.78%-5.59M
-120.12%-195.56K
13.13%-1.68M
-5.48%-1.88M
-10.18%-1.85M
End cash Position
157.86%232.42K
157.86%232.42K
269.46%1.06M
-94.27%112.49K
-43.01%2.19M
-98.41%90.14K
-98.41%90.14K
-93.94%285.7K
-70.46%1.96M
-54.41%3.84M
Free cash flow
21.41%-5.2M
21.33%-789.88K
17.91%-1.36M
-1.59%-1.91M
44.91%-1.15M
-2.03%-6.62M
15.13%-1M
29.94%-1.65M
-58.97%-1.88M
-18.15%-2.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 27.99%-4.76M28.81%-714.88K24.33%-1.25M12.20%-1.64M44.74%-1.15M-9.51%-6.6M33.55%-1M-2.40%-1.65M-59.56%-1.87M-19.75%-2.08M
Net income from continuing operations 26.24%-8.03M27.91%-1.99M51.03%-1.25M20.03%-2.24M8.05%-2.55M-63.68%-10.89M-2,952.08%-2.77M-2.75%-2.55M-54.17%-2.8M-13.08%-2.77M
Operating gains losses 11.46%223.55K2,013.04%191.44K-61.98%8.16K-103.21%-3.79K-61.00%27.74K19.08%200.56K-104.68%-10.01K-80.83%21.47K--117.98K--71.12K
Depreciation and amortization 159.89%200.89K610.12%141.6K3.91%20.5K-9.58%-38.15K6.21%76.95K-53.46%77.3K-74.87%19.94K-57.49%19.73K-209.99%-34.82K737.14%72.45K
Other non cash items 421.38%900.13K56.56%152.87K691.47%356.16K--167.72K--223.38K-85.47%172.64K-43.67%97.64K-42.18%45K--------
Change In working capital -68.17%471.7K-52.77%524.67K-309.72%-649.17K-82.20%44.08K396.73%552.12K141.10%1.48M136.14%1.11M171.27%309.55K238.51%247.68K74.13%-186.07K
-Change in receivables -137.64%-63.4K-307.14%-23.77K-182.43%-41.87K1,010.16%24.81K-173.59%-22.57K7.27%-26.68K-860.16%-5.84K-861.48%-14.83K-99.53%2.24K98.37%-8.25K
-Change in inventory -103.74%-905-162.24%-10.29K1,283.27%25.8K-172.01%-9.1K-6.69%-7.32K207.90%24.17K531.60%16.53K104.71%1.87K-28.07%12.64K-130.37%-6.86K
-Change in prepaid assets -566.88%-432.09K-323.63%-257.07K116.51%9.49K-534.93%-123.84K-211.19%-60.68K174.15%92.55K333.88%114.95K-483.20%-57.47K82.16%-19.5K191.93%54.57K
-Change in payables and accrued expense 15.56%1.05M-27.43%478.6K-67.49%72.35K-154.09%-2.58K2,551.39%498.17K570.71%905.62K872.40%659.48K-0.46%222.58K102.18%4.76K-91.26%18.79K
-Change in other current liabilities -2,112.20%-141.38K2,539.82%28.64K-13,462.99%-171.85K-0.77%58.6K-4.35%-56.77K113.05%7.03K103.31%1.09K107.55%1.29K4,007.09%59.06K-890.80%-54.41K
-Change in other working capital -86.87%62.93K-4.97%308.55K-447.90%-543.09K-48.97%96.18K205.99%201.29K113.65%479.36K111.16%324.68K335.39%156.11K295.73%188.49K56.69%-189.92K
Cash from discontinued investing activities
Operating cash flow 27.99%-4.76M28.81%-714.88K24.33%-1.25M12.20%-1.64M44.74%-1.15M-9.51%-6.6M33.55%-1M-2.40%-1.65M-59.56%-1.87M-19.75%-2.08M
Investing cash flow
Cash flow from continuing investing activities -2,971.87%-2.49M287.86%33.29K-74,973.70%-2.26M-5,234.66%-261.51K89.68%-8.45K96.23%-81.22K100.94%8.58K99.06%-3.01K99.19%-4.9K73.50%-81.89K
Net PPE purchase and sale -4,023.52%-444.72K-55,655.56%-75K-4,091.21%-108.22K-9,643.11%-261.51K--097.41%-10.79K-99.96%13599.65%-2.58K---2.68K---5.65K
Net intangibles purchase and sale --0--0--0--0--095.01%-1.94K--086.51%-42690.52%-60796.86%-910
Net business purchase and sale -2,893.41%-2.05M1,181.84%108.29K---2.15M--088.79%-8.45K95.97%-68.49K100.58%8.45K--099.82%-1.61K---75.33K
Cash from discontinued investing activities
Investing cash flow -2,971.87%-2.49M287.86%33.29K-74,973.70%-2.26M-5,234.66%-261.51K89.68%-8.45K96.23%-81.22K100.94%8.58K99.06%-3.01K99.19%-4.9K73.50%-81.89K
Financing cash flow
Cash flow from continuing financing activities 578.31%7.39M-117.69%-141.53K17,753.12%4.45M-169.86K933.34%3.26M-71.10%1.09M-76.48%800K-25.2K0-14.83%315K
Net issuance payments of debt 108.11%1.66M-117.69%-141.53K--1.45M---190.15K--544K420.00%800K--800K--0--0--0
Net common stock issuance 1,867.55%5.7M---23.05K11,989.13%3M--20.3K759.89%2.71M-92.06%289.8K--0---25.2K--0--315K
Proceeds from stock option exercised by employees --25.43K--23.05K--0---1--2.38K--0--0--0--0--0
Cash from discontinued financing activities
Financing cash flow 578.31%7.39M-117.69%-141.53K17,753.12%4.45M---169.86K933.34%3.26M-71.10%1.09M-76.48%800K---25.2K--0-14.83%315K
Net cash flow
Beginning cash position -98.41%90.14K269.46%1.06M-94.27%112.49K-43.01%2.19M-98.41%90.14K-43.70%5.68M-93.94%285.7K-70.46%1.96M-54.41%3.84M-43.70%5.68M
Current changes in cash 102.54%142.29K-320.90%-823.12K156.25%943.06K-10.55%-2.08M213.72%2.1M-26.78%-5.59M-120.12%-195.56K13.13%-1.68M-5.48%-1.88M-10.18%-1.85M
End cash Position 157.86%232.42K157.86%232.42K269.46%1.06M-94.27%112.49K-43.01%2.19M-98.41%90.14K-98.41%90.14K-93.94%285.7K-70.46%1.96M-54.41%3.84M
Free cash flow 21.41%-5.2M21.33%-789.88K17.91%-1.36M-1.59%-1.91M44.91%-1.15M-2.03%-6.62M15.13%-1M29.94%-1.65M-58.97%-1.88M-18.15%-2.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg